Precisis
Heidelberg, DE · 1 known investors
PRECISIS develops bioelectronic therapies for neurological conditions, including EASEE, a minimally invasive neurostimulation system implanted under the scalp to treat drug-resistant focal epilepsy without brain surgery. The company targets patients with medication-resistant epilepsy and the medical professionals who treat them.
HardwareHealthtechMedical Devices